Ascensia Diabetes Care announced today that it launched the Eversense 365 CGM system from Senseonics (NYSE:SENS) ...

Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...

Previously, CGMs have only been available as medical devices for people ... which announced the US availability of its own prescription-free CGM shortly after Dexcom had cleared its own.) ...

More and more people are talking abut the monitoring device, also known as CGM, for non-diabetics ... I prefer less medical intervention, and as little as possible for as long as I can get ...

Continuous glucose monitoring enhanced by geriatric care principles reduced the duration of hypoglycemia without worsening ...

Ascensia Diabetes Care, a global diabetes care company, announces that it is launching the Eversense ® 365 continuous glucose monitoring (CGM ... ("Senseonics") is a medical technology company ...

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

The case for Abbott Laboratories. Abbott Laboratories is one of the world's leading medical device makers. It routinely ...

Senseonics Holdings, Inc. (NYSE American: SENS) ("Senseonics" or the "Company"), a medical technology company focused on the ...

In recent years, digital health has become a new development trend in the global health and medical industry. By using ...

CompuGroup Medical (CGM) has appointed Dr. Thomas Speckmann as its Global Head of Communications, starting November 1, 2024.